Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Risk factors for bronchopleural complications after pneumonectomy].

Khirurgiia·2025
Same author

[Surgical heritage of academician Bogush L.K. and its influence on modern thoracic and phthisiatric surgery].

Khirurgiia·2024
Same author

[Pulmonary fibrosis after a new coronavirus infection - versions and controversies: A review].

Terapevticheskii arkhiv·2024
Same author

Can Shrews Avoid Competition When Hutchinson's Ecological Rule Is Disobeyed?

Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections·2023
Same author

Lifespans of Fur Color Morphs in Polymorphic Populations of the Mole Vole and the Hypothesis of Adaptive Polymorphism.

Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections·2023
Same author

Possibilities of non-invasive diagnosis of fibrotic phenotype of interstitial lung diseases.

Terapevticheskii arkhiv·2023

Related Experiment Video

Updated: May 13, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

[Chemotherapy of tuberculosis: problems and perspectives].

I A Vasil'eva, A G Samoĭlova, A E Ergeshov

    Vestnik Rossiiskoi Akademii Meditsinskikh Nauk
    |March 6, 2013
    PubMed
    Summary

    Drug-resistant tuberculosis (DR-TB) significantly reduces treatment success. Early diagnosis and individualized therapy with second-line drugs are crucial for effective management of DR-TB patients.

    More Related Videos

    A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
    10:29

    A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

    Published on: March 24, 2017

    Related Experiment Videos

    Last Updated: May 13, 2026

    An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
    09:34

    An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

    Published on: August 16, 2021

    A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
    10:29

    A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

    Published on: March 24, 2017

    Area of Science:

    • Infectious Diseases
    • Pulmonary Medicine
    • Microbiology

    Context:

    • High burden of drug-resistant tuberculosis (DR-TB) poses significant challenges to global health.
    • Standard chemotherapy regimens are becoming less effective due to increasing DR-TB.
    • Analysis of treatment outcomes for 1658 patients with new and relapsed tuberculosis cases.

    Purpose:

    • To evaluate the efficacy of standard tuberculosis chemotherapy regimens in the context of rising drug resistance.
    • To identify risk factors associated with unfavorable treatment outcomes in pulmonary tuberculosis.
    • To highlight the importance of rapid diagnostics and individualized therapy for DR-TB.

    Summary:

    • Favorable treatment results were observed in drug-susceptible tuberculosis cases.
    • Efficacy of standard regimens decreases with increasing drug resistance (DR) amplification.
    • Primary isoniazid resistance (OR=2.1) and multidrug resistance (MDR-TB, OR=8.0) are key risk factors for poor outcomes.

    Impact:

    • Early diagnosis and tailored second-line drug therapy improve culture conversion (97.7%) and cavity closure (82.7%) in MDR-TB patients.
    • Highlights the need for rapid diagnostics to guide effective individualized treatment strategies.
    • Emphasizes the declining efficacy of standard regimens necessitates a shift towards personalized medicine in TB treatment.